OTC Markets OTCPK - Delayed Quote USD

CannaPharmaRX, Inc. (CPMD)

Compare
0.0080 0.0000 (0.00%)
At close: December 11 at 3:00:00 PM EST
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
338.0030
--
--
--
--
Operating Expense
164.2000
1,581.1040
5,211.8090
2,616.4700
4,638.1750
Operating Income
-1,408.2230
-1,581.1040
-5,211.8090
-2,616.4700
-4,638.1750
Net Non Operating Interest Income Expense
-2,458.5810
-1,690.9240
-2,290.3190
-1,507.3910
-2,293.8580
Other Income Expense
5,246.8370
6,960.4840
-1,028.8920
-4,708.6380
-12,958.2380
Pretax Income
1,380.0330
3,688.4560
-8,531.0200
-8,832.4990
-19,890.2720
Net Income Common Stockholders
1,380.0330
3,688.4560
-8,531.0200
-8,832.4990
-19,890.2720
Diluted NI Available to Com Stockholders
1,380.0330
3,688.4560
-8,531.0200
-8,832.4990
-19,890.2720
Basic EPS
0.01
0.01
-0.04
-0.12
-0.49
Diluted EPS
0.01
0.01
-0.04
-0.12
-0.49
Basic Average Shares
549,017.7420
308,937.7100
211,044.3570
74,686.5630
40,699.9510
Diluted Average Shares
549,017.7420
308,937.7100
211,044.3570
74,686.5630
40,699.9510
Total Operating Income as Reported
-1,385.5500
-1,581.1040
-5,211.8090
-2,993.1690
-14,486.1720
Rent Expense Supplemental
3.2920
2.5990
12.3070
--
35.8130
Total Expenses
1,746.2260
1,581.1040
5,211.8090
2,616.4700
4,638.1750
Net Income from Continuing & Discontinued Operation
1,380.0330
3,688.4560
-8,531.0200
-8,832.4990
-19,890.2720
Normalized Income
-4,489.3233
-246.7676
-7,099.7340
-4,123.8610
-6,932.0340
Interest Expense
2,463.3070
1,690.9240
2,290.3190
1,507.3910
2,293.8580
Net Interest Income
-2,458.5810
-1,690.9240
-2,290.3190
-1,507.3910
-2,293.8580
EBIT
3,843.3400
5,379.3800
-6,240.7010
-7,325.1080
-17,596.4140
EBITDA
3,834.5610
5,507.2270
-5,945.7670
-7,322.4000
-17,467.9090
Reconciled Depreciation
-8.7790
127.8470
294.9340
2.7080
128.5050
Net Income from Continuing Operation Net Minority Interest
1,380.0330
3,688.4560
-8,531.0200
-8,832.4990
-19,890.2720
Total Unusual Items Excluding Goodwill
6,905.1250
6,558.7060
-1,431.2860
-4,708.6380
-12,958.2380
Total Unusual Items
6,905.1250
6,558.7060
-1,431.2860
-4,708.6380
-12,958.2380
Normalized EBITDA
-3,070.5640
-1,051.4790
-4,514.4810
-2,613.7620
-4,509.6710
Tax Rate for Calcs
0.0002
0.0004
--
--
--
Tax Effect of Unusual Items
1,035.7688
2,623.4824
--
--
--
12/31/2020 - 10/29/1999

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers